Y Intercept Hong Kong Ltd boosted its stake in AMERISAFE, Inc. (NASDAQ:AMSF – Free Report) by 123.4% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 13,186 shares of the insurance provider’s stock after buying an additional 7,283 shares during the quarter. Y Intercept Hong Kong Ltd’s holdings in AMERISAFE were worth $637,000 at the end of the most recent quarter.
A number of other institutional investors also recently modified their holdings of the stock. Jane Street Group LLC raised its holdings in shares of AMERISAFE by 70.6% during the third quarter. Jane Street Group LLC now owns 41,299 shares of the insurance provider’s stock worth $1,996,000 after acquiring an additional 17,084 shares in the last quarter. State Street Corp raised its stake in shares of AMERISAFE by 8.5% during the 3rd quarter. State Street Corp now owns 811,561 shares of the insurance provider’s stock worth $39,223,000 after purchasing an additional 63,638 shares in the last quarter. Jacobs Levy Equity Management Inc. lifted its holdings in shares of AMERISAFE by 3.5% during the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 19,008 shares of the insurance provider’s stock valued at $919,000 after buying an additional 645 shares during the last quarter. HighTower Advisors LLC grew its stake in shares of AMERISAFE by 13.8% in the 3rd quarter. HighTower Advisors LLC now owns 7,940 shares of the insurance provider’s stock valued at $388,000 after buying an additional 962 shares in the last quarter. Finally, Martingale Asset Management L P increased its holdings in AMERISAFE by 5.7% in the third quarter. Martingale Asset Management L P now owns 22,294 shares of the insurance provider’s stock worth $1,077,000 after buying an additional 1,200 shares during the last quarter. Institutional investors and hedge funds own 97.41% of the company’s stock.
AMERISAFE Stock Performance
Shares of AMSF stock opened at $53.70 on Friday. The company has a market capitalization of $1.02 billion, a price-to-earnings ratio of 16.78 and a beta of 0.33. The stock’s 50 day simple moving average is $55.07 and its 200 day simple moving average is $49.47. AMERISAFE, Inc. has a twelve month low of $41.97 and a twelve month high of $60.24.
AMERISAFE Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, December 13th. Shareholders of record on Friday, December 6th were issued a dividend of $3.37 per share. This represents a $13.48 dividend on an annualized basis and a yield of 25.10%. This is a boost from AMERISAFE’s previous quarterly dividend of $0.37. The ex-dividend date of this dividend was Friday, December 6th. AMERISAFE’s dividend payout ratio is 46.25%.
Analyst Ratings Changes
A number of analysts have issued reports on the stock. Truist Financial lifted their target price on shares of AMERISAFE from $48.00 to $54.00 and gave the company a “hold” rating in a research note on Friday, October 25th. JMP Securities reiterated a “market outperform” rating and issued a $65.00 price objective on shares of AMERISAFE in a report on Tuesday, October 15th.
Get Our Latest Stock Report on AMSF
AMERISAFE Profile
AMERISAFE, Inc, an insurance holding company, underwrites workers’ compensation insurance in the United States. The company provides benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. It sells its products through retail and wholesale brokers and agents; and small and mid-sized employers engaged in hazardous industries, including construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications, and maritime.
Further Reading
- Five stocks we like better than AMERISAFE
- How to Buy Cheap Stocks Step by Step
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- 3 Warren Buffett Stocks to Buy Now
- Texas Instruments: The Old-School Tech Titan Still Delivering
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Want to see what other hedge funds are holding AMSF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMERISAFE, Inc. (NASDAQ:AMSF – Free Report).
Receive News & Ratings for AMERISAFE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMERISAFE and related companies with MarketBeat.com's FREE daily email newsletter.